基本信息
views: 39
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Mariano Esteban is an internationally recognized scientist with a long experience in molecular basis of pathogenesis by infectious agents. In particular, his group has made important contributions in understanding the life cycle of vaccinia virus, virus-host cell interactions and the mechanism of action of interferons. Mariano Esteban used this knowledge to develop vaccinia virus vectors as candidate vaccines against diseases like AIDS, malaria and leishmaniasis. His group, in collaboration with colleagues in New York, pioneered a heterologous prime/boost approach that has gained acceptance as an immunization protocol against multiple infectious agents. Esteban's group has developed candidate vaccines against HIV/AIDS that are in clinical trials.
Research Interests
Papers共 491 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Enrique Alvarez,Michela Falqui,Laura Sin, Joseph Patrick Mcgrail,Beatriz Perdiguero,Rocio Coloma,Laura Marcos-Villar, Celine Tarrega,Mariano Esteban,Carmen Elena Gomez,Susana Guerra
VACCINESno. 2 (2024): 153
npj Vaccinesno. 1 (2024): 1-15
NPJ VACCINESno. 1 (2024)
VACCINESno. 1 (2024): 15
FRONTIERS IN IMMUNOLOGY (2023): 1264323-1264323
Frontiers in immunology (2023): 1172427-1172427
Frontiers in Immunology (2023): 1163159
Beatriz Perdiguero,Alexandra Hauser,Carmen Elena Gomez,David Peterhoff, Eleftheria Sideris,Carlos Oscar S. Sorzano,Sarah Wilmschen, Marion Schaber, Laura Stengel,Benedikt Asbach,Song Ding,Dorothee Von Laer,
FRONTIERS IN IMMUNOLOGY (2023): 1270908-1270908
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn